BIOPHYTIS (ALBPS.PA) Stock Cash Flow
Europe - Euronext Paris - EPA:ALBPS - FR001400OLP5 - Common Stock
0.08 EUR
+0 (+0.63%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -21.86M | -24.22M | -17.03M | -24.22M | -31.25M | |||
| Depreciation Amortization | 543.00K | 484.00K | 803.00K | 484.00K | 311.00K | |||
| Change In Working Capital | 3.05M | 540.00K | 1.01M | 540.00K | -52.00K | |||
| Interest Paid | 115.00K | 662.00K | 460.00K | 662.00K | 562.00K | |||
| Other non cash items | 1.54M | 4.21M | 2.34M | 4.21M | 7.19M | |||
| OPERATING CASH FLOW | -16.73M | -18.99M | -12.87M | -18.99M | -23.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -141.00K | -220.00K | -141.00K | -344.00K | |||
| Other Investing Activity | 124.00K | 124.00K | 590.00K | 124.00K | 12.50M | |||
| INVESTING CASH FLOW | -8.00K | -17.00K | 370.00K | -17.00K | 12.16M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 6.21M | 7.43M | 2.37M | 7.43M | 17.50M | |||
| Stock Issued/Repurchased | N/A | N/A | 5.54M | N/A | 16.58M | |||
| Other Financing Activity | -761.00K | -1.29M | -884.00K | -1.29M | -4.37M | |||
| FINANCING CASH FLOW | 8.37M | 6.13M | 7.03M | 6.13M | 29.71M | |||
| Exchange Rate Effect | N/A | -3.00K | -9.00K | -3.00K | -1.00K | |||
| CHANGE IN CASH | -8.37M | -12.87M | -5.49M | -12.87M | 18.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.73M | -18.99M | -12.87M | -18.99M | -23.80M | |||
| Capital Expenditure | N/A | -141.00K | -220.00K | -141.00K | -344.00K | |||
| FREE CASH FLOW | -16.86M | -19.13M | -13.09M | -19.13M | -24.14M | |||
All data in EUR